Startups
Egle Therapeutics

Egle Therapeutics

https://egle-tx.com

Biotechnology firm developing immunotherapies for cancer and autoimmune diseases.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 64

Locations

Company Size

  • 11 - 51

Last Stage Round

Insights

Egle Therapeutics, based in Paris, is developing advanced immunotherapies for cancer and autoimmune diseases. Unlike traditional treatments, which often have severe side effects and limited effectiveness, Egle's approach aims to offer better outcomes with fewer side effects. By targeting immune system mechanisms, Egle can potentially transform patient experiences and increase survival rates. Their B2B model, supported by investors like Bioqube Ventures, positions them to form strategic partnerships and secure resources for growth, making them a promising contender in health tech.

Total Funding
$46.2M

Investors

Full Company Profile